Capsules Recall: HANDELNINE GLOBAL Rheumacare 30-count bottle
Announced 2026-02-11 · FDA
FDA recalls Rheumacare capsules manufactured in India by Virgo UAP Pharma Pvt. Ltd., Ahmedabad, due to CGMP deviations with detected lead. Four bottles (30 capsules each) were distributed to one customer in New York. Recall numbers CAM040 (Exp 06/30/2029) and CAL079-N (Exp 09/30/2028).
| Brand | HANDELNINE GLOBAL LLC |
|---|---|
| Product | Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313 |
| Reason | CGMP Deviations: product found to contain lead. |
| Severity | critical |
| Units affected | 4 |
| Distribution | Product was distributed to one customer in NY. |
| Agency | FDA |
| Recall / campaign no. | Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028 |
WHAT YOU SHOULD DO
- Do not use the recalled Rheumacare capsules.
- If you have Lot CAM040 or Lot CAL079-N, stop using them and discard or return to the retailer for a refund.
- Check bottles for the lot numbers CAM040 or CAL079-N and follow recall instructions from HANDELNINE GLOBAL for disposal.
- Contact HANDELNINE GLOBAL for recall instructions and safety guidance, or monitor FDA updates for additional instructions.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.